文献速递关节外科运动医学

髋关节镜下圆韧带重建:至少2年随访的临床结局

Arthroscopic Ligamentum Teres Reconstruction in the Hip: Clinical Outcomes With Minimum 2-Year Follow-up.
PubMed 文献 · Am J Sports Med · 2025-09-03

回顾性分析2014至2021年22例接受胫骨前肌同种异体移植物关节镜下圆韧带重建的患者。末次随访时改良Harris髋关节评分、非关节炎髋关节评分、髋关节结局评分-运动专项子量表、12项国际髋关节结局工具评分及疼痛视觉模拟评分均显著改善,患者满意度高,95.5%存活率。作者认为在同时处理盂唇修复和股骨髋臼撞击成形时该术式结局良好,但最佳移植物选择尚无定论。

要点

  • 22例患者接受胫骨前肌同种异体移植关节镜下圆韧带重建,至少随访2年。
  • 改良Harris髋关节评分、非关节炎髋关节评分、髋关节结局评分-运动专项子量表、12项国际髋关节结局工具评分及疼痛视觉模拟评分均显著改善。
  • 患者满意度高,95.5%存活率,并发症及全髋关节置换转换率低。

核心结论

  • 关节镜下胫骨前肌同种异体移植圆韧带重建,同时行盂唇修复和股骨髋臼撞击成形术,在至少2年随访中显示出良好结局、高患者满意度和高比例患者达到临床重要阈值,并发症及全髋关节置换转换率低。
  • 最佳移植物选择尚未明确,移植物选择取决于外科医生的培训、熟悉程度、具体情况和资源。

研究设计与样本

  • 病例系列研究,证据等级4级;回顾性分析2014至2021年间接受关节镜下胫骨前肌同种异体移植圆韧带重建的所有患者数据。
  • 纳入患者共22例,术前及术后至少2年完成患者报告结局问卷,包括改良Harris髋关节评分、非关节炎髋关节评分、髋关节结局评分-运动专项子量表、12项国际髋关节结局工具评分、疼痛视觉模拟评分和患者满意度评分,或研究时间范围内有记录的终点。
  • 计算了上述患者报告结局的最小临床重要差异并纳入分析,同时评估了存活率。

主要发现

  • 共纳入22例患者。
  • 改良Harris髋关节评分、非关节炎髋关节评分、髋关节结局评分-运动专项子量表、12项国际髋关节结局工具评分和疼痛视觉模拟评分均显示显著改善。
  • 末次随访时观察到患者满意度评分高。
  • 高比例患者达到改良Harris髋关节评分、非关节炎髋关节评分、髋关节结局评分-运动专项子量表和疼痛视觉模拟评分的计算最小临床重要差异。
  • 患者存活率为95.5%。

关键数值与推荐

  • 纳入患者22例;存活率95.5%。
  • 改良Harris髋关节评分、非关节炎髋关节评分、髋关节结局评分-运动专项子量表、12项国际髋关节结局工具评分和疼痛视觉模拟评分均显著改善,具体数值原文未报告。
  • 患者满意度评分高,具体数值原文未报告。
  • 高比例患者达到改良Harris髋关节评分、非关节炎髋关节评分、髋关节结局评分-运动专项子量表和疼痛视觉模拟评分的计算最小临床重要差异,具体比例原文未报告。

临床怎么用

  • 原文结论为关节镜下胫骨前肌同种异体移植圆韧带重建联合盂唇修复和股骨髋臼撞击成形术在至少2年随访中显示出良好结局、高患者满意度和高比例患者达到临床重要阈值,并发症及全髋关节置换转换率低。
  • 作者认为移植物选择取决于外科医生的培训、熟悉程度、具体情况和资源,最佳移植物选项尚未明确。

局限性

  • 原文结论指出最佳移植物选项尚未明确。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The ligamentum teres (LT) plays an important role in the general stability of the hip joint. A high prevalence of concomitant LT pathology has been noted in patients undergoing hip arthroscopy. This increased prevalence has led to the development of multiple treatment options, including reconstruction techniques using different types of grafts. The current literature on outcomes of LT reconstruction is limited. PURPOSE: To evaluate the outcomes of LT reconstruction with tibialis anterior allograft treatment for LT tears with a minimum 2-year follow-up. STUDY DESIGN: Case series; Level of evidence, 4. METHODS: Data were retrospectively analyzed for all patients who underwent arthroscopic LT reconstruction with a tibialis anterior allograft between 2014 and 2021. Preoperatively and a minimum of 2 years postoperatively, included patients had completed questionnaires for the following patient-reported outcome (PRO) measures: modified Harris Hip Score (mHHS), Non-Arthritic Hip Score (NAHS), Hip Outcome Score-Sports Specific Subscale (HOS-SSS), 12-item International Hip Outcome Tool (iHOT-12) score, visual analog scale (VAS) for pain score, and patient satisfaction score; or they had a documented endpoint within the study's time frame. The minimal clinically important difference (MCID) was calculated for the mentioned PROs and included in the analysis. Survivorship was also evaluated and included in the analysis. RESULTS: A total of 22 patients were included in the study. Significant improvement was shown in mHHS, NAHS, HOS-SSS, iHOT-12 score, and VAS pain score. A high patient satisfaction score was also observed at the latest follow-up. Furthermore, a high percentage of patients reached the calculated MCID for the mHHS, NAHS, HOS-SSS, and VAS score. Patients demonstrated 95.5% survivorship. CONCLUSION: Arthroscopic LT reconstruction with a tibialis anterior allograft, concomitant with labral repairs and osteoplasties for femoroacetabular impingement, has shown favorable outcomes, high patient satisfaction rates, and a high percentage of patients reaching clinically important thresholds, with a low rate of complications and total hip arthroplasty conversion at a minimum 2-year follow-up. Furthermore, the choice of a graft rests in the hands of the surgeon based on training, familiarity, circumstances, and resources, as the optimal graft option has yet to be elucidated.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Domb BG, Walsh EG, Strok MJ, et al. Arthroscopic Ligamentum Teres Reconstruction in the Hip: Clinical Outcomes With Minimum 2-Year Follow-up. Am J Sports Med. 2025. PMID: 40901704. doi:10.1177/03635465251352826

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。